Clinical trial Recruiting at 23 sites Observational Ages 18 and up

InRAD international registry for Alzheimer's disease and related dementias

Official title: The International Registry for Alzheimer's Disease and Other Dementias (InRAD): An International Registry Observational Study Dedicated to Evaluating Outcomes Data in Alzheimer's Disease

Run by Stichting International Registry for Alzheimer's Disease and other Dementias Foundation · NCT07213700 · Data updated 2026-11-12

This project will collect routine medical information over time to see how Alzheimer's disease, mild cognitive impairment, and related dementias progress and how current treatments are tolerated in adults.

More Mild Cognitive Impairment (MCI) trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50000 (estimated)
SponsorStichting International Registry for Alzheimer's Disease and other Dementias Foundation
Academic / other
Locations23 sites (Melbourne and 22 other locations)
StatusRecruiting
StartedMarch 30, 2026
Main results expectedJanuary 2036
Study endsJanuary 2036
Registry record updatedNovember 6, 2026
Trial IDNCT07213700 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults undergoing diagnostic work-up for Alzheimer's disease or with a confirmed AD diagnosis (treated or untreated) who receive care at an InRAD-affiliated center and can provide informed consent are eligible.

Probably not a fit

People who cannot or will not provide informed consent, or who do not attend an InRAD center, are unlikely to receive direct benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The InRAD Observational Study is a prospective, non-interventional, multinational registry that collects real-world clinical data from adults undergoing diagnostic work-up for or living with Alzheimer's disease. Participating centers record demographics, comorbidities, diagnostic and monitoring tests, medication exposures, cognitive and functional measures, and adverse events during routine care, typically with at least annual visits. Data are pseudonymized and pooled to allow comparison of disease trajectories, treatment safety, and outcomes across countries and regions over many years. Operational management and system support are provided by the InRAD Foundation while individual centers remain the data controllers.

Why it matters

Potential benefit: If successful, the registry could improve understanding of long-term disease course and treatment safety, helping clinicians make better care and monitoring decisions for patients with dementia.

How similar studies have gone: Large observational registries and consortia (for example ADNI and national dementia registries) have produced useful insights into progression and treatment effects, so this registry approach is established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Be undergoing diagnostic work-up for Alzheimer's disease (AD), OR
* Have a confirmed diagnosis of AD (whether currently treated with an AD-specific treatment, or untreated),
* Be attending an InRAD Center,
* Have provided informed consent for long-term follow-up

Exclusion Criteria:

-Any patient or legal representative who is unable or unwilling to provide a signed informed consent form

The protocol does not specify a lower or upper age limit. Participants are expected to be predominantly adults, and can include younger adults with early-onset or genetically determined Alzheimer's disease (e.g. Down syndrome-associated Alzheimer's disease).

Where it's running

  • Alfred Hospital
    Melbourne, Australia
    Recruiting
  • Medical University of Graz
    Graz, Austria
    Recruiting
  • Kardinal Schwarzenberg Klinikum
    Schwarzach, Austria
    Recruiting
  • UZLeuven
    Leuven, Belgium
    Recruiting
  • Irmandade da Santa Casa de São Paulo
    São Paulo, Brazil
    Recruiting
  • Motol and Homolka University Hospital (UHM)
    Prague, Czechia
    Recruiting
Show 17 more locations
  • Ain Shams University
    Cairo, Egypt
    Recruiting
  • Aiginition Hospital
    Athens, Greece
    Recruiting
  • Panhellenic Federation of Alzheimer's Disease and Related Disorders
    Thessaloniki, Greece
    Recruiting
  • The Adelaide and Meath Hospital
    Dublin, Ireland
    Recruiting
  • B.R.A.N.D. Center - Neurologia Universitaria - Policinico Foggia
    Foggia, Italy
    Recruiting
  • Ospedale San Raffaele
    Milan, Italy
    Recruiting
  • Stichting Amsterdam UMC (location VUmc) - ABOARD Cohort
    Amsterdam, Netherlands
    Recruiting
  • Stichting Amsterdam UMC (location VUmc) - Amsterdam Dementia Cohort
    Amsterdam, Netherlands
    Recruiting
  • NeuroProtect
    Warsaw, Poland
    Recruiting
  • Hospital de Santo António
    Porto, Portugal
    Recruiting
  • County Emergency Clinic Hospital Brasov/Spitalul Clinic Judetean de Urgenta Brasov
    Brasov, Romania
    Recruiting
  • Saint Luke Hospital for Chronic Disease-Geriatrics and Gerontology II
    Bucharest, Romania
    Recruiting
  • Fundatia Ana Aslan International
    Bucharest, Romania
    Recruiting
  • King Faisal Specialist Hospital
    Riyadh, Saudi Arabia
    Recruiting
  • Fundació ACE, Institut Català de Neurociències Aplicades
    Barcelona, Spain
    Recruiting
  • New Taipei Municipal TuCheng Hospital
    New Taipei City, Taiwan
    Recruiting
  • Istanbul University Çapa Hospital
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • China HEAD: a large community study on healthy aging and dementia

    This study tests whether collecting health, imaging, and biospecimen data from adults in China can help predict who will develop Alzheimer’s disease and related dementias.

    Recruiting at 30 sites Fudan University · Beijing and 29 other locations · NCT07912710

  • Aging Brain Health Initiative in Fujian

    This observational study will follow about 3,000 older adults in Fujian to see how Alzheimer's-related changes develop and to test new digital tests, biomarkers, and imaging tools for early diagnosis.

    Recruiting at 4 sites Fujian Medical University Union Hospital · Fushun, Fujian and 3 other locations · NCT07891429

  • Digital tools to predict Alzheimer's biology from risk factors

    This study tests a digital, AI-based tool that analyzes modifiable and non-modifiable risk factors to see if it can predict biological changes linked to Alzheimer's disease in adults with MCI or SCD.

    Recruiting at 2 sites IRCCS Centro San Giovanni di Dio Fatebenefratelli · Brescia, BS and 1 other locations · NCT07731191

  • Community screening with blood biomarkers for Alzheimer's in older adults

    This project will test whether two blood biomarkers (pTau217/Aβ42 ratio and GFAP) can detect Alzheimer's disease or mild cognitive impairment in community-dwelling older adults.

    Recruiting at 4 sites Shanghai Fengxian District Central Hospital · Shanghai, Shanghai Municipality and 3 other locations · NCT07570719

  • Online positive psychology program to support thinking and brain health in early memory changes

    This study will test whether an online positive psychology program can improve thinking, brain function, and wellbeing in older adults with early memory problems (Subjective Cognitive Decline or Mild Cognitive Impairment).

    Recruiting Aristotle University Of Thessaloniki · Thessaloniki · NCT07289061

  • Personalized digital training for cognitive fitness in people with mild cognitive impairment

    This study tests whether a personalized home-based digital program (RICORDO) helps people aged 50 and older with mild cognitive impairment or subjective cognitive decline manage their health and daily life better than a paper-and-video education program.

    Recruiting at 2 sites University of Modena and Reggio Emilia · Modena, Reggio Nell'Emilia (RE) and 1 other locations · NCT07286448

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.